ARTARMON, Australia, Jan. 21, 2020 /PRNewswire/ -- Saluda Medical Pty Limited ("Saluda Medical") today announced that data from multiple studies evaluating the company's Evoke ® ECAP-Controlled, ...
Evoke is a novel, closed-loop SCS system that instantaneously reads, records, and responds to evoked compound action potentials. The Food and Drug Administration (FDA) has approved the Evoke ® Spinal ...
There’s another company poised to make an impact on the way chronic pain is treated in the U.S. Artarmon, Australia-based Saluda Medical has just won FDA approval for the Evoke Spinal Cord Stimulation ...
MINNEAPOLIS, Feb. 5, 2025 /PRNewswire/ -- Saluda Medical, Inc., a pioneer in the development and commercialization of a novel neuromodulation platform designed to transform the lives of patients with ...
BLOOMINGTON, Minn., July 16, 2026 /PRNewswire/ -- Saluda Medical, Inc. (ASX: SLD, "Saluda" or the "Company"), a commercial‑stage medical device company advancing closed‑loop neuromodulation for ...
BLOOMINGTON, Minn., June 30, 2026 /PRNewswire/ -- Saluda Medical, Inc. (ASX: SLD, "Saluda" or the "Company"), a commercial-stage medical device company focused on developing treatments for chronic ...
The UK’s Newcastle Hospitals National Health Service (NHS) Foundation Trust has fitted a teenage patient with a spinal cord stimulator (SCS) implant, making the patient the first adolescent in the UK, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results